Stem cell biologists have tried unsuccessfully for years to produce cells that will give rise to functional arteries and offer physicians new options for combating cardiovascular disease, the world’s leading cause of death.
But new techniques developed by scientists from UC Santa Barbara, the University of Wisconsin-Madison and the Morgridge Institute for Research have produced, for the first time, functional arterial cells at both the quality and scale to be relevant for disease modeling and clinical application.